Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.

Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance.

Downey KK, Helmus TC, Schuster CR.

Exp Clin Psychopharmacol. 2000 May;8(2):176-84.

PMID:
10843300
2.

Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.

Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR.

Arch Gen Psychiatry. 1999 Sep;56(9):812-20.

PMID:
12884887
3.

Naltrexone and buprenorphine combination in the treatment of opioid dependence.

Gerra G, Fantoma A, Zaimovic A.

J Psychopharmacol. 2006 Nov;20(6):806-14.

PMID:
16401652
4.

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, Rounsaville BJ, Pakes JA, Schottenfeld RS.

Am J Med. 1998 Aug;105(2):100-5.

PMID:
9727815
5.

Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.

Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL.

Arch Gen Psychiatry. 1996 May;53(5):409-15.

PMID:
8624184
6.

Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.

Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.

J Subst Abuse Treat. 2006 Jul;31(1):3-7. Review.

PMID:
16814005
7.

Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program.

Katz EC, Chutuape MA, Jones HE, Stitzer ML.

Exp Clin Psychopharmacol. 2002 May;10(2):136-43.

PMID:
12022799
8.

Thrice-weekly versus daily buprenorphine maintenance.

Schottenfeld RS, Pakes J, O'Connor P, Chawarski M, Oliveto A, Kosten TR.

Biol Psychiatry. 2000 Jun 15;47(12):1072-9.

PMID:
10862807
9.

Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.

Messinis L, Lyros E, Andrian V, Katsakiori P, Panagis G, Georgiou V, Papathanasopoulos P.

Hum Psychopharmacol. 2009 Oct;24(7):524-31. doi: 10.1002/hup.1050.

PMID:
19650155
10.

Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude.

Silverman K, Chutuape MA, Bigelow GE, Stitzer ML.

Psychopharmacology (Berl). 1999 Sep;146(2):128-38.

PMID:
10525747
11.

Single- versus dual-drug target: effects in a brief abstinence incentive procedure.

Correia CJ, Dallery J, Katz EC, Silverman K, Bigelow G, Stitzer ML.

Exp Clin Psychopharmacol. 2003 Nov;11(4):302-8.

PMID:
14599264
12.

Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.

Oliveto A, Kosten TR, Schottenfeld R, Falcioni J, Ziedonis D.

J Subst Abuse Treat. 1995 Nov-Dec;12(6):423-8.

PMID:
8749726
13.

A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.

Gross A, Marsch LA, Badger GJ, Bickel WK.

Exp Clin Psychopharmacol. 2006 May;14(2):148-56.

PMID:
16756418
14.
15.

Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.

Epstein DH, Schmittner J, Umbricht A, Schroeder JR, Moolchan ET, Preston KL.

Drug Alcohol Depend. 2009 Apr 1;101(1-2):92-100. doi: 10.1016/j.drugalcdep.2008.11.006.

16.

Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence.

Sofuoglu M, Gonzalez G, Poling J, Kosten TR.

Am J Drug Alcohol Abuse. 2003;29(4):713-27.

PMID:
14713135
17.

Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.

Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K.

Drug Alcohol Depend. 2003 Jun 5;70(3):315-25.

PMID:
12757969
18.
19.

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.

Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.

Arch Gen Psychiatry. 2005 Oct;62(10):1148-56.

PMID:
16203960
Items per page

Supplemental Content

Support Center